Screener
Madrigal Pharmaceuticals, Inc. MDGL Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $292.88M+53.2% | $232.19M+23.1% | $203.78M+94.0% | $300.69M+26.5% | $191.19M-61.7% | ||
| $546.03M-10.6% | $585.74M-11.2% | $784.87M-5.0% | $814.06M+6.3% | $610.83M+8.5% | ||
| $192.31M+143% | $187.36M+205% | $134.48M+150% | $113.29M+272% | $79.23M+1,048% | ||
| $99.39M+56.5% | $112.07M+103% | $74.84M+120% | $69.32M+695% | $63.5M+798% | ||
| $1.2B+19.5% | $1.18B+19.7% | $1.25B+20.6% | $1.35B+26.6% | $1B-8.1% | ||
| $11.59M+618% | $8.04M+323% | $1.5M-31.6% | $2.91M+28.4% | $1.62M-4.7% | ||
| $7.19M+58.0% | $7.28M+57.0% | $7.38M+56.1% | $7.48M+55.2% | $4.55M-7.4% | ||
| $1.24B+22.6% | $1.23B+23.1% | $1.26B+20.9% | $1.36B+26.9% | $1.02B-7.7% | ||
| $34.51M-9.1% | $60.8M+44.6% | $48.88M+12.1% | $44.94M-2.2% | $37.98M+322% | ||
| $30.1M+159% | $29.98M+158% | —— | $31.06M+155% | $11.6M-9.1% | ||
| $374.2M+90.4% | $338.26M+102% | $310.29M+83.3% | $391.41M+120% | $196.5M+57.0% | ||
| $340.79M+188% | $340.33M+188% | $339.88M+189% | $339.75M+190% | $118.38M+1.5% | ||
| $346.72M+182% | $345.61M+191% | $346.61M+192% | $345.32M+192% | $122.9M+4.6% | ||
| $720.92M+126% | $683.87M+139% | $656.9M+128% | $736.73M+149% | $319.4M+31.6% | ||
| 200M0.0% | 200M0.0% | 2K0.0% | 200M0.0% | 200M0.0% | ||
| -$2.24B-17.0% | -$2.18B-16.5% | -$2.09B-16.0% | -$2.03B-16.6% | -$1.92B-17.2% | ||
| $523.72M-24.7% | $543.45M-23.5% | $602.69M-20.1% | $625.73M-19.5% | $695.98M-18.8% | ||
| $1.24B+22.6% | $1.23B+23.1% | $1.26B+20.9% | $1.36B+26.9% | $1.02B-7.7% |
FAQ
- What are Madrigal Pharmaceuticals, Inc.'s total assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) holds $1.2B in total assets, up 22.6% year over year.
- How much debt does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. carries $377.9M in total debt against $523.7M of shareholders' equity, a debt-to-equity ratio of 0.72.
- How much cash does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. holds $292.9M in cash and equivalents.
- Can Madrigal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.20 — current assets exceed current liabilities.
- Where does Madrigal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
